End-Stage Renal Disease and Sudden Cardiac Death

Area of Science:

• Nephrology
• Cardiology
• Clinical Medicine

Background:

• Patients with end-stage renal disease (ESRD) exhibit a significantly elevated risk for sudden cardiac death (SCD).
• Ventricular arrhythmias are identified as the primary mechanism for SCD in this vulnerable population, mirroring trends in the general populace.
• Metabolic disturbances unique to ESRD, coupled with prevalent traditional risk factors, contribute to the heightened SCD risk.

Purpose of the Study:

• To review current data on risk factors for SCD in ESRD patients.
• To evaluate the efficacy of medical and device-based therapies for SCD prevention and treatment in this cohort.
• To assess the applicability of established risk stratification methods for SCD in ESRD.

Main Methods:

• Literature review of existing studies on SCD in ESRD.
• Analysis of data concerning risk factors, therapies, and risk stratification tools.
• Synthesis of current evidence to inform clinical practice.

Main Results:

• ESRD patients face a disproportionately high risk of SCD, primarily due to ventricular arrhythmias.
• Metabolic derangements and traditional risk factors exacerbate SCD risk in ESRD.
• Limited evidence exists for effective SCD assessment and management strategies in this population.

Conclusions:

• Further research is crucial to develop targeted strategies for SCD prevention and management in ESRD.
• Risk stratification tools need validation for their applicability in the ESRD population.
• Addressing unique metabolic and traditional risk factors is key to reducing SCD in ESRD patients.